[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note",
    "summary": "Vertex Pharmaceuticals (VRTX) closed at $468.41 in the latest trading session, marking a +1.64% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=b6e65f66f8e8f67391e0633894804a26fc021dc0e98b229f6cc745734f4612e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753825802,
      "headline": "Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note",
      "id": 136130075,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals (VRTX) closed at $468.41 in the latest trading session, marking a +1.64% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=b6e65f66f8e8f67391e0633894804a26fc021dc0e98b229f6cc745734f4612e3"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=a16230410d2b94148fdc592f8da6b1957b810d2c9fc57d4118c1f060b4d8ccce",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753807080,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 136136404,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=a16230410d2b94148fdc592f8da6b1957b810d2c9fc57d4118c1f060b4d8ccce"
    }
  },
  {
    "ts": null,
    "headline": "Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "summary": "Harmony Biosciences (HRMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=1a1eaef9d02365dbad5a15ef3b0cb38b0c4ec24d36e7702774bda38fb0854cd1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753797606,
      "headline": "Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
      "id": 136119405,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Harmony Biosciences (HRMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=1a1eaef9d02365dbad5a15ef3b0cb38b0c4ec24d36e7702774bda38fb0854cd1"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards?",
    "summary": "VRTX eyes second-quarter growth with surging Trikafta sales. Investors' focus is likely to be on the progress of Casgevy, and Alyftrek and Journavx launches.",
    "url": "https://finnhub.io/api/news?id=ea450f0efc1b9c063e9ea94bf58f8e8209ba15a09191c2bdbd7ec6f2c0740c52",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753794840,
      "headline": "Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards?",
      "id": 136119406,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "VRTX eyes second-quarter growth with surging Trikafta sales. Investors' focus is likely to be on the progress of Casgevy, and Alyftrek and Journavx launches.",
      "url": "https://finnhub.io/api/news?id=ea450f0efc1b9c063e9ea94bf58f8e8209ba15a09191c2bdbd7ec6f2c0740c52"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=d1f92a98a210c591ab2b515f5118db94010d810792eeb109a93a3ce7882389fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753794003,
      "headline": "Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know",
      "id": 136119407,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=d1f92a98a210c591ab2b515f5118db94010d810792eeb109a93a3ce7882389fa"
    }
  },
  {
    "ts": null,
    "headline": "LEAD3R Launches 2025 Healthy Team Summit, Sponsored by The Future of Teamwork Podcast",
    "summary": "In a time of rapid change, team fatigue, and fractured collaboration, LEAD3R is proud to unveil the 2025 Healthy Team Summit, a full-day \"un-conference\" designed to help teams thrive – not just survive.",
    "url": "https://finnhub.io/api/news?id=1c6f3605c8d5fab7a6a362210f90f45c2cb60e76961cd79e2a0a00bc70008a38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753787040,
      "headline": "LEAD3R Launches 2025 Healthy Team Summit, Sponsored by The Future of Teamwork Podcast",
      "id": 136117140,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "In a time of rapid change, team fatigue, and fractured collaboration, LEAD3R is proud to unveil the 2025 Healthy Team Summit, a full-day \"un-conference\" designed to help teams thrive – not just survive.",
      "url": "https://finnhub.io/api/news?id=1c6f3605c8d5fab7a6a362210f90f45c2cb60e76961cd79e2a0a00bc70008a38"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Growth Fund Q2 2025 Commentary",
    "summary": "U.S. equities rebounded strongly from tariff and geopolitical scares to deliver healthy gains in the second quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=dbb15590710e3bbcd27b4af22bdb6b8148bcc093c372e51393cbaffacbc46911",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753786140,
      "headline": "ClearBridge Growth Fund Q2 2025 Commentary",
      "id": 136118470,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "U.S. equities rebounded strongly from tariff and geopolitical scares to deliver healthy gains in the second quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=dbb15590710e3bbcd27b4af22bdb6b8148bcc093c372e51393cbaffacbc46911"
    }
  }
]